These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy. Coulter DL; Allen RJ Lancet; 1980 Jun; 1(8181):1310-1. PubMed ID: 6104123 [No Abstract] [Full Text] [Related]
26. [The decreased level of plasma carnitine in patients with epilepsy]. Belousova ED Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):106-110. PubMed ID: 28745680 [TBL] [Abstract][Full Text] [Related]
27. Drug induced encephalopathy in six epileptic patients: topiramate? valproate? or both? Latour P; Biraben A; Polard E; Bentué-Ferrer D; Beauplet A; Tribut O; Allain H Hum Psychopharmacol; 2004 Apr; 19(3):193-203. PubMed ID: 15079854 [TBL] [Abstract][Full Text] [Related]
28. [Valproic acid-induced hyperammonemic encephalopathy in a patient receiving valproic acid monotherapy]. Yamada H; Shishido T; Mukai T; Araki M; Naka H; Tokinobu H Rinsho Shinkeigaku; 2019 May; 59(5):258-263. PubMed ID: 31061301 [TBL] [Abstract][Full Text] [Related]
29. Impaired fatty acid oxidation in children on valproic acid and the effect of L-carnitine. Kossak BD; Schmidt-Sommerfeld E; Schoeller DA; Rinaldo P; Penn D; Tonsgard JH Neurology; 1993 Nov; 43(11):2362-8. PubMed ID: 8232957 [TBL] [Abstract][Full Text] [Related]